Supplement Library
Testing Article SE
December 2021 | Volume 20 | Issue 12 | Case Reports | 1 | Copyright © December 2021
Test Abstract...
Read MoreTesting Article Courtney 3
December 2021 | Volume 20 | Issue 12 | Case Reports | 1 | Copyright © December 2021
test edited...
Read MoreTesting Article 2 Courtney
December 2021 | Volume 20 | Issue 12 | Case Reports | 1 | Copyright © December 2021
abstract 1...
Read MoreTest Article 5
May 2016 | Volume 15 | Issue 5 | Original Article | ABC Test First | Copyright © May 2016
Abstract Test Text...
Read MoreTesting Test Article 300
December 2021 | Volume 20 | Issue 12 | Original Article | First Page Test | Copyright © December 2021
Abstract Test text...
Read MoreSafe Use of Adapalene 0.1 % Gel in a non-Prescription Environment
December 2021 | Volume 20 | Issue 12 | Original Article | 6527 | Copyright © December 2021
SE HERE
Background: Topical retinoids are the mainstay of acne therapy and, until 2016, were only available by prescription. The margin of safety (MOS) of adapalene for potential...
Read MoreFULL SUPPLEMENT: ALGORITHM FOR PRE-/POST-PROCEDURE MEASURES FOR FACIAL NONENERGY-BASED AND INJECTABLE SKIN TREATMENTS
November 2021 | Volume 20 | Issue 11 | Department | ss1121 | Copyright © November 2021
A panel of dermatologists and plastic surgeons convened a virtual meeting to develop an algorithm for measures before, during, and after nonenergy and injectable treatments based on the best available...
Read MoreINDIVIDUAL ARTICLE: Algorithm for Nonenergy and Injectable Treatment Pre-/Post-Procedure Measures
November 2021 | Volume 20 | Issue 11 | Supplement Individual Articles | ss3s | Copyright © November 2021
Background: Nonenergy and injectable treatments are frequently used for facial rejuvenation. Many publications have addressed methods to reduce adverse events related to the procedure...
Read MoreINDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials
October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s4s4 | Copyright © October 2021
Background: Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple opti...
Read MoreINDIVIDUAL ARTICLE: The Importance of Local Tolerability and Duration of Therapy in Topical Actinic Keratosis Treatment
October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s3s3 | Copyright © October 2021
Actinic keratoses (AK) are among the most common dermatologic presentations, with estimates suggesting that they account for approximately 15 percent of dermatologic diagnoses in the US.1 Incidence of...
Read MoreFULL SUPPLEMENT: TIRBANIBULIN 1% OINTMENT FOR ACTINIC KERATOSIS LESS PAIN, MORE GAIN
October 2021 | Volume 20 | Issue 10 | Department | s3s | Copyright © October 2021
Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple options for the topical treatment...
Read MoreUS Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm
September 2021 | Volume 20 | Issue 9 | Supplement Individual Articles | 3ss | Copyright © September 2021
Background: An increasing number of patients survive or are living with cancer. Anticancer treatments frequently have cutaneous adverse events (cAEs) that may severely impact patients...
Read MoreFULL SUPPLEMENT: Skincare for Cancer Patients and Survivors
September 2021 | Volume 20 | Issue 9 | Department | 2s | Copyright © September 2021
Background: An increasing number of patients survive or are living with cancer. Anticancer treatments frequently have cutaneous adverse events (cAEs) that may severely impact patients...
Read MoreClinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma Management
June 2021 | Volume 20 | Issue 6 | Supplement Individual Articles | 5s | Copyright © June 2021
Gene expression profile (GEP) testing is now commercially available for metastatic risk prediction in patients with cutaneous squamous cell carcinoma (CSCC) and one or more high-risk factors. The purp...
Read MoreBridging the Gap: Integrating Gene Expression Profiling into Clinical Practice
June 2021 | Volume 20 | Issue 6 | Supplement Individual Articles | s4 | Copyright © June 2021
FULL SUPPLEMENT: Integrating Gene Expression Profiling into the Management of Cutaneous Squamous Cell Carcinoma
June 2021 | Volume 20 | Issue 6 | Department | 1ss | Copyright © June 2021
This supplement provides an early framework for healthcare providers looking to integrate patient-specific tumor biology into their clinical practice using GEP testing. Gene expression profile (GEP) t...
Read MoreARTICLE: Advances in Oral Isotretinoin Therapy
May 2021 | Volume 20 | Issue 5 | Supplement Individual Articles | s5 | Copyright © May 2021
Since its approval in 1982, oral isotretinoin has revolutionized acne therapy. However, oral isotretinoin use has long been associated with challenges of variable bioavailability and food dependence. ...
Read MoreARTICLE: Why Absorica LD?
May 2021 | Volume 20 | Issue 5 | Supplement Individual Articles | 3s | Copyright © May 2021
FULL SUPPLEMENT: Status Update: Isotretinoin
May 2021 | Volume 20 | Issue 5 | Department | 1s | Copyright © May 2021
FULL SUPPLEMENT: Skin Barrier and Skin Health
April 2021 | Volume 20 | Issue 4 | Department | s1 | Copyright © April 2021
